Share
 
Title
Treatment Optimisation: Lessons from ADVANCE, DolPHIN 2 and NAMSAL trials
Code
SA047
Session Type
Satellite
Format
Hybrid
ROOM/CHANNEL
Room 517b/Channel 4
Date Time
30 July 08:00 - 09:00
Chair
Mireille MPOUDI NGOLE - ETAME, ANRS - Cameroon, Cameroon
Moderators
Charles KOUANFACK, Dschang University, Faculty of medicine and pharmaceutical sciences, Cameroon
Sinata KOULLA, University of Yaoundé, Cameroon
Polly CLAYDEN, HIV i-Base, United Kingdom
Angela TEMBO, Ezintsha, South Africa
Helen REYNOLDS, University of Liverpool, United Kingdom
Catriona WAITT, University of Liverpool, United Kingdom
Organizer
The TRIO team led by Ezintsha

We will share information on the three UNITAID funded clinical trials (TRIO), highlighting the main findings from the combined analyses. We also want to showcase the human element of the trials with presentations on best practices in stakeholder engagement. Further to this, we will detail experiences from the field with first hand experiences of health care workers and participants.

08:00
2 min
 Opening
Mireille MPOUDI NGOLE - ETAME, ANRS - Cameroon, Cameroon
08:02
18 min
 Session 1: Joint analysis results
Sinata KOULLA, University of Yaoundé, Cameroon
Andrew HILL, Liverpool University, United Kingdom
Charles KOUANFACK, Dschang University, Faculty of medicine and pharmaceutical sciences, Cameroon
Marco VITORIA, WORLD HEALTH ORGANIZATION, Switzerland
08:20
5 min
 Q&A
Andrew HILL, Liverpool University, United Kingdom
Charles KOUANFACK, Dschang University, Faculty of medicine and pharmaceutical sciences, Cameroon
Sinata KOULLA, University of Yaoundé, Cameroon
Marco VITORIA, WORLD HEALTH ORGANIZATION, Switzerland
08:25
15 min
 Session 2: Community Engagement
Tamara TOVAR-SANCHEZ, IRD, France
Luckyboy MKHONDWANE, Treatment Action Campaign, South Africa
Angela TEMBO, Ezintsha, South Africa
Polly CLAYDEN, HIV i-Base, United Kingdom
Catriona WAITT, University of Liverpool, United Kingdom
08:40
5 min
 Q&A
Polly CLAYDEN, HIV i-Base, United Kingdom
Angela TEMBO, Ezintsha, South Africa
Tamara TOVAR-SANCHEZ, IRD, France
Luckyboy Edison MKHONDWANE, Treatment Action Campaign, South Africa
Catriona WAITT, University of Liverpool, United Kingdom
08:45
5 min
 Voices from the ground
Mpho Elizabeth MOLEFE, Ezintsha, South Africa
Sibongiseni NXUMALO, Ezintsha, South Africa
Helen REYNOLDS, University of Liverpool, United Kingdom
Catriona WAITT, University of Liverpool, United Kingdom
08:50
5 min
 Q&A
Mpho Elizabeth MOLEFE, Ezintsha, South Africa
Helen REYNOLDS, University of Liverpool, United Kingdom
Sibongiseni NXUMALO, Ezintsha, South Africa
Catriona WAITT, University of Liverpool, United Kingdom
08:55
5 min
 Session 4: Closing remarks
Meg DOHERTY, World Health Organization, Switzerland
Martina PENAZZATO, WHO HQ, Switzerland
Robert MATIRU, WHO/Unitaid, Switzerland
Yazdan YAZDANPANAH, ITMO I3M - INSERM, France
Francoise RENAUD, WHO HQ, Switzerland